CAS: 151213-39-7; (4As,7As)-6-Benzyloctahydro-1H-Pyrrolo[3,4-B]Pyridine

该化合物是一个双环化合物,其特点是独特的引信环状结构,包括一种丙烯和,其特征是苯氧基组,它具有疏水特性和生物系统互动潜力.4aS,7aS)的命名表明,立体化学学表明,氢原子和替代体在手工业中心周围的具体空间安排可以对其再生活动和生物活动产生重大影响.八氢框架意味着该化合物完全饱和,通常比不饱和的模拟物增强稳定性和减少回性.该物质可能具有有趣的药理学特性,成为医学化学进一步研究的候选物.其化学文摘社编号为1511313-39-7,它允许在化学数据库中精确识别,便利与其合成,应用和潜在治疗用途有关的研究.总体而言,该化合物的结构特征表明它可以在各种化学和生物过程中发挥作用.

结构式图片

相似化合物

151213-40-0 159877-36-8 147459-51-6

欧盟法规

C&L通报REACH预注册

上下游产品

(S,S)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane-D-tartrate [1S,6R]-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane (S,S)-8-benzyl-2,8-diazabicyclo[4.3.0]nonane tartrate salt (1S,6S)-2,8-diazabicyclo[4.3.0]nonane

合成工艺路线路线简述

    📜(3S)-1-Benzyl-3-Amino-4-(3-Chloropropyl)Pyrrolidine置于potassium Tert-Butylate,四丁基碘化铵体系中,用 四氢呋喃 用作溶剂,化学反应 1.0H,以92.5%的收率获得(S,S)-6-苄基-八氢吡咯并[3,4-B]吡啶双盐酸盐
    参考文献:一种3-氨基吡咯烷化合物及其合成方法和用 途
    标题:一种3-氨基吡咯烷化合物及其合成方法和用 途
    摘要:本发明涉及一种3‑氨基吡咯烷化合物及其合成方法和用途,是以3‑ 吡咯烷酮化合物( 化合物iiia或iiib)为底物,在转氨酶和氨基供体的作用下,发生转氨酶反应得到(S)-3-氨基吡咯烷化合物(化合物ii);再发生分子内关环,脱除氨基保护基得到(S,S)‑2,8‑二氮杂双环[4,3,0]壬烷(化合物i).本发明为莫西沙星中间体提供了一种成本低,工艺流程短,对环境友好的合成技术,将具有巨大的市场应用价值,适合大规模工业化生产.

    海关参考信息

    专利信息


    专利号:US-8680276-B2
    优先权日:2009-03-06
    标题 :Synthesis of (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine
    发明人:MOTTERLE RICCARDO; ARVOTTI GIANCARLO; BERGANTINO ELISABETTA; CASTELLIN ANDREA; FOGAL STEFANO; GALVAGNI MARCO
    权利人:MOTTERLE RICCARDO; ARVOTTI GIANCARLO; BERGANTINO ELISABETTA; CASTELLIN ANDREA; FOGAL STEFANO; GALVAGNI MARCO
    摘要:The present invention relates to the stereoselective synthesis of (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine, as well as the conversion thereof, to give Moxifloxacin. Particularly, the present invention relates to a method for the synthesis of (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine of formula (I) comprising: (a) the optical resolution by enzymatic hydrolysis of the intermediate dialkyl-1-alkylcarbonylpiperidine-2,3-dicarboxylate racemate of formula (II) to give, following isolation, the intermediate dialkyl-(2S,3R)-1-alkylcarbonyl-piperidine-2,3-dicarboxylate of formula (III) in which AIk is a straight or branched C1-C5 alkyl group; (b) the conversion of the intermediate (III) to (4aR,7aS)-1-alkylcarbonylhexahydrofuro[3,4-b]pyridine-5,7-dione of formula (IV) in which AIk has the meanings set forth above; (c) the conversion of the intermediate (IV) to (4aS,7as)-octahydro-1H-pyrrolo[3,4-b]pyridine of formula (I) with an optical purity above 99%.

    专利号:WO-2012131629-A1
    优先权日:2011-03-31
    标题 :A process for preparation of intermediate of moxifloxacin
    发明人:WANKHEDE KARUNA; JAGTAP ASHUTOSH; ROY MITA; HARIHARAN SIVARAMAKRISHNAN; KUMBHAR AJAY
    权利人:PIRAMAL HEALTHCARE LTD; WANKHEDE KARUNA; JAGTAP ASHUTOSH; ROY MITA; HARIHARAN SIVARAMAKRISHNAN; KUMBHAR AJAY
    摘要:The present invention provides a process for the preparation of racemic or chiral octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine of formula I, a key intermediate in the synthesis of moxifloxacin or its pharmaceutically acceptable salts. The process comprises reaction of racemic or chiral tetrahydro-6-(phenylmethyl)-1H- pyrrolo[3,4-b]pyridine-5,7(6H)-dione of formula II with a reducing agent, which is a mixture of two agents, that is mixture of dimethyl sulphate and sodium borohydride or aluminum chloride and sodium borohydride used in a molar ratio ranging from 1:1 to 1: 4, in the presence of a polar solvent at a temperature ranging from 15°C to 45°C 10 to obtain racemic or chiral octahydro-6-(phenylmethyl)-1H-pyrrolo[3,4-b]pyridine of formula I having purity ≥ 96%.

    专利号:CN-115073452-A
    优先权日:2022-06-11
    标 题:A method for continuous synthesis of moxifloxacin side chain intermediates by heterogeneous hydrogenation in a microreactor

    专利号:US-2011137036-A1
    优先权日:2009-03-06
    标题 :SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE

    专利号:WO-2010100215-A1
    优先权日:2009-03-06
    标题:SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE

    专利号:EP-2403831-B1
    优先权日:2009-03-06
    标题 :SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLOÃ?3,4-b¨PYRIDINE

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知